Murphy, Middleton, Hinkle & Parker, Inc. Pfizer Inc Transaction History

Murphy, Middleton, Hinkle & Parker, Inc.

$185 Million
Q3 2024

A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 39,219 shares of PFE stock, worth $1.07 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

39,219

Previous 40,131 2.27%

Holding current value

$1.07 Million

Previous $1.12 Million 1.07%

% of portfolio

0.61%

Previous 0.65%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $25,262 - $28,627	-912 Reduced 2.27%	39,219 $1.13 Million
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $20,713 - $24,272	-820 Reduced 2.0%	40,131 $1.12 Million
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $31,352 - $36,003	-1,211 Reduced 2.87%	40,951 $1.14 Million
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $137,234 - $178,252	-5,252 Reduced 11.08%	42,162 $1.21 Million
Q3 2023 Oct 03, 2023	BUY	$32.09 - $37.51 $26,024 - $30,420	811 Added 1.74%	47,414 $1.57 Million
Q2 2023 Jul 05, 2023	SELL	$36.12 - $41.79 $52,951 - $61,264	-1,466 Reduced 3.05%	46,603 $1.71 Million
Q1 2023 Apr 05, 2023	BUY	$39.39 - $51.28 $157 - $205	4 Added 0.01%	48,069 $1.96 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $17,702 - $23,108	-424 Reduced 0.87%	48,065 $2.46 Million
Q3 2022 Oct 07, 2022	BUY	$43.76 - $53.42 $52,512 - $64,104	1,200 Added 2.54%	48,489 $2.12 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $33,548 - $39,777	721 Added 1.55%	47,289 $2.48 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $40,397 - $50,057	-883 Reduced 1.86%	46,568 $2.41 Million
Q4 2021 Jan 13, 2022	SELL	$41.32 - $61.25 $36,113 - $53,532	-874 Reduced 1.81%	47,451 $2.8 Million
Q3 2021 Oct 07, 2021	BUY	$39.25 - $50.42 $12,677 - $16,285	323 Added 0.67%	48,325 $2.08 Million
Q2 2021 Jul 13, 2021	SELL	$35.91 - $40.68 $22,048 - $24,977	-614 Reduced 1.26%	48,002 $1.88 Million
Q1 2021 Apr 08, 2021	SELL	$33.49 - $37.77 $31,045 - $35,012	-927 Reduced 1.87%	48,616 $1.76 Million
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $3,246 - $4,128	-97 Reduced 0.2%	49,543 $1.82 Million
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $75,279 - $88,319	-2,371 Reduced 4.56%	49,640 $1.82 Million
Q2 2020 Jul 08, 2020	BUY	$30.12 - $36.54 $29,577 - $35,882	982 Added 1.92%	52,011 $1.7 Million
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $7,081 - $10,118	262 Added 0.52%	51,029 $1.67 Million
Q4 2019 Jan 08, 2020	SELL	$32.92 - $37.36 $35,191 - $39,937	-1,069 Reduced 2.06%	50,767 $1.99 Million
Q1 2019 Apr 17, 2019	SELL	$37.5 - $41.2 $90,262 - $99,168	-2,407 Reduced 4.44%	51,836 $2.2 Million
Q2 2018 Jul 13, 2018	BUY	$32.98 - $35.16 $1.79 Million - $1.91 Million	54,243 New	54,243 $1.97 Million

Others Institutions Holding PFE

# of Institutions

3,245

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy, Middleton, Hinkle & Parker, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Murphy, Middleton, Hinkle & Parker, Inc. with notifications on news.

Account

Murphy, Middleton, Hinkle & Parker, Inc. Pfizer Inc Transaction History